Reporting owner · Q3 2026 · CIK 1403497

Stern Adam K: insider trades.

Stern Adam K reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 2 companies.

Transactions
6
Purchases (P)
0
Sales (S)
0
Companies
2
Name as filed
STERN ADAM K

Companies

CompanyRelationshipTransactions
DarioHealth Corp. (DRIO)Director3
Matinas BioPharma Holdings, Inc. (MTNB)TenPercentOwner3

Transactions

6 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-24DarioHealth Corp.A28,000$057,717Form 4
2026-07-10Matinas BioPharma Holdings, Inc.X630,335$0.35743,785Form 4
2026-07-10Matinas BioPharma Holdings, Inc.X344,710$0.35416,900Form 4
2025-10-31Matinas BioPharma Holdings, Inc.X92,100$0.64113,450Form 4
2025-09-18DarioHealth Corp.C8,435$16.626,341Form 4
2025-09-18DarioHealth Corp.C11,760$40.417,906Form 4

Questions

What stock did Stern Adam K buy or sell?

Stern Adam K reported 6 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 2 companies.

Is Stern Adam K the same person as other filers with this name?

This page covers SEC CIK 1403497 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/stern-adam-k-1403497.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.